Jundishapur Journal of Microbiology

Published by: Kowsar

Frequency of Hepatitis B and C Viruses, and HIV Among Drug Addicts in the Eastern Anatolia, Turkey

Nuran Karabulut 1 , * , Yasemin Bulut 2 and Selda Telo 3
Authors Information
1 Department of Medical Microbiology, Mental Health Hospital, Elazig, Turkey
2 Department of Medical Microbiology, Medical Faculty, Firat University, Elazig, Turkey
3 Department of Medical Biochemistry, Mental Health Hospital, Elazig, Turkey
Article information
  • Jundishapur Journal of Microbiology: August 01, 2015, 8 (8); e19698
  • Published Online: August 29, 2015
  • Article Type: Research Article
  • Received: May 5, 2014
  • Revised: September 12, 2014
  • Accepted: October 18, 2014
  • DOI: 10.5812/jjm.19698

To Cite: Karabulut N, Bulut Y, Telo S. Frequency of Hepatitis B and C Viruses, and HIV Among Drug Addicts in the Eastern Anatolia, Turkey, Jundishapur J Microbiol. 2015 ; 8(8):e19698. doi: 10.5812/jjm.19698.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health. 2007; 84(3): 436-54[DOI][PubMed]
  • 2. Bertoletti A, Gehring AJ. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control? PLoS Pathog. 2013; 9(12)[DOI][PubMed]
  • 3. Clark F. Global drug policy fuels hepatitis C epidemic, report warns. Lancet. 2013; 381(9881): 1891[PubMed]
  • 4. Bekolo CE, Nguena MB, Ewane L, Bekoule PS, Kollo B. The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population. BMC Public Health. 2014; 14: 236[DOI][PubMed]
  • 5. Tahaei SM, Mohebbi SR, Azimzadeh P, Vahedi M, Almasi S, Romani S, et al. Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010. Hepat Mon. 2011; 11(12): 993-6[DOI][PubMed]
  • 6. Altay T, Uskun E, Akcam FZ. Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey. Braz J Infect Dis. 2012; 16(4): 339-44[DOI][PubMed]
  • 7. Janahi EM. Prevalence and risk factors of hepatitis B virus infection in Bahrain, 2000 through 2010. PLoS One. 2014; 9(2)[DOI][PubMed]
  • 8. Akcam FZ, Uskun E, Avsar K, Songur Y. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey. Int J Infect Dis. 2009; 13(2): 274-84[DOI][PubMed]
  • 9. Oliveira MLA, Bastos FI, Telles PR, Yoshida CFT, Schatzmayr HG, Paetzold U, et al. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Brazilian J Med Biol Res. 1999; 32(9)[DOI]
  • 10. Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul Nutr. 2000; 18(3): 145-50[PubMed]
  • 11. McMahon JM, Simm M, Milano D, Clatts M. Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. 2004; 3: 6[DOI][PubMed]
  • 12. Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, et al. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduct J. 2009; 6: 22[DOI][PubMed]
  • 13. Medina Mora ME. In support of substance use disorders. Addiction. 2011; 106(5): 887-8[DOI][PubMed]
  • 14. Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. Iran Red Crescent Med J. 2011; 13(1): 42-6[PubMed]
  • 15. Öner S, Yapıcı G, Şaşmaz CT, Kurt AO, Buğdaycı R. Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey. Turk J Med Sci. 2011; 41(2): 335-41
  • 16. Yenen O, Beyazyürek M, Keskin K, Çavuşlu, Ş. , Sakarya, S. , Altunay, H. . Prevalence of HBsAg, Anti-HBc, anti-HCV, anti-HTLV-1, anti-HIV-1/2 in intravenous drug abusers. Klimik Derg. 1993; 6: 35-6
  • 17. Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M, Salman F, et al. Risk factors of hepatitis B virus infection in Turkey: A population-based, case-control study: Risk Factors for HBV Infection. Hepat Mon. 2011; 11(4): 263-8[PubMed]
  • 18. Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol. 1998; 14(6): 555-61[PubMed]
  • 19. Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health. 2011; 11: 351[DOI][PubMed]
  • 20. Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill. 2011; 16(36): 19962
  • 21. Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill. 2011; 16(48): 8-14
  • 22. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012; 23(4): 271-8[DOI][PubMed]
  • 23. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002; 92(3): 385-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments